June 5, 2007 - GE Healthcare introduced at SNM a new version of the company’s Discovery Dimension designed to help ...
June 5, 2007 - GVI Medical Devices, Inc., extended its nuclear cardiology line with the introduction of ClearVision ...
June 4, 2007 — Contrary to recent studies, proper use of a drug called aprotinin to reduce bleeding during heart surgery does not increase the risk of heart attack or stroke, according to a study in the June issue of The Journal of Thoracic and Cardiovascular Surgery.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
June 4, 2007 — A new radiological test, used to detect acute coronary trauma has the ability to save valuable time and ...
June 4, 2007 — Biodegradable magnesium stents have been developed to treat blockages in coronary arteries. The stents will degrade within four months and achieve the same results as conventional stents, conclude authors of an article published in this week's edition of The Lancet.
June 1, 2007 — New findings show that the majority of people untrained in how to perform cardiopulmonary resuscitation ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
June 1, 2007 — Abbott announced it has completed its application to the U.S. Food and Drug Administration (FDA) to seek market approval for its XIENCE V Everolimus Eluting Coronary Stent System to treat coronary artery disease, with the submission of the final module of its Pre-Market Approval (PMA) application.
June 1, 2007 —ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, was ...
June 1, 2007 — Siemens recently announced the introduction of Syngo DynaCT Cardiac, which provides three-dimensional ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
May 31, 2007 - The American Heart Association is launching a community-based program to reduce the toll of the deadliest kind of heart attack: an ST-elevation myocardial infarction (STEMI). The total blockage of a coronary artery is fatal unless treated quickly — within 30 minutes for clot-dissolving drug treatment, and within 90 minutes for angioplasty.
May 31 -- Cardiac Science Corp. announced today it has entered into a two-year marketing partnership with the City of ...
May 31, 2007 — MediNotes Corporation, a leading provider of best-of-breed electronic medical record solutions for small ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
May 30, 2007 -- Daxor Corp., a medical instrumentation and biotechnology company, announced the June 2007 publication of ...
May 30, 2007 -- Xtalks and eResearchTechnology will present a Web conference titled, "Best Practices in Cardiac Safety Data Collection Before and After the Thorough QT Trial," on June 7, 10 a.m. to noon, EDT.
May 30, 2007 -- The Canadian Press reports this week that people in the greatest need of cardiac medications and interventions are less likely than moderately ill patients to get the full range of heart drugs and procedures, and it may be because they fail the "eyeball" test.